Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 1 institution in 1 country.
Rufine AzonsivoPostgraduate Program in Pharmaceutical Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.
Kelly Cristina Oliveira de AlbuquerquePostgraduate Program in Biodiversity and Biotechnology of the BIONORTE Network, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0001-6448-0689
Ana Laura Gadelha CastroPostgraduate Program in Pharmaceutical Innovation, Federal University of Pará, Belém 66075-110, PA, Brazil.
Juliana Correa-BarbosaPostgraduate Program in Pharmaceutical Innovation, Federal University of Pará, Belém 66075-110, PA, Brazil.
Helena Joseane Raiol de SouzaPostgraduate Program in Risk and Natural Disaster Management in the Amazon, Federal University of Pará, Belém 66075-110, PA, Brazil.
Andryo Orfi de Almada-VilhenaCenter for Advanced Studies of the Biodiversity and Cell Culture Laboratory, Guamá Science and Technology Park, Federal University of Pará, Belém 66075-750, PA, Brazil.ORCID 0000-0002-5113-4215
Gleison Gonçalves FerreiraPostgraduate Program in Pharmaceutical Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0002-3682-7945
Anderson Albuquerque de SouzaFaculty of Pharmacy, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0003-2349-9679
Andrey Moacir do Rosario MarinhoFaculty of Chemistry, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0002-8981-0995
Sandro PercarioPostgraduate Program in Biodiversity and Biotechnology of the BIONORTE Network, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0002-9528-0361
Cleusa Yoshiko NagamachiCenter for Advanced Studies of the Biodiversity and Cell Culture Laboratory, Guamá Science and Technology Park, Federal University of Pará, Belém 66075-750, PA, Brazil.
Julio Cesar PieczarkaCenter for Advanced Studies of the Biodiversity and Cell Culture Laboratory, Guamá Science and Technology Park, Federal University of Pará, Belém 66075-750, PA, Brazil.ORCID 0000-0003-2951-8877
Maria Fâni DolabelaPostgraduate Program in Pharmaceutical Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0003-0804-5804
Universidade Federal do Pará · BR
Funding
National Council for Scientific and Technological Development 432458/2018.2Pró-Reitoria de Pesquisa e Pós-Graduação Edital PAPQ 02/2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cytotoxicity and Genotoxicity Evaluation of · full record | OpenQuestion